Dunlop, A., Lokuge, B., Masters, D., Sequeira, M., Saul, P., Dunlop, G., Ryan, J., Hall, M., Ezard, N., Haber, P., Lintzeris, N., & Maher, L. (2020). Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction Journal, 17(1). doi:10.1186/s12954-020-00370-7

Dyer, M.L., et al., State anxiety and alcohol choice: Evidence from experimental and online observational studies. Journal of Psychopharmacology, 2020. 34(11): p. 1237-1249.

Farrell, M., & Robertson, R. (2020). Commentary on Ho et al. (2020): Managing people with HIV and drug problems is complex and multi-faceted. Addiction, 115(4), 653-654. doi:10.1111/add.14950

Fetene, D. M., Higgs, P., Nielsen, S., Djordjevic, F., & Dietze, P. (2020). The impact of Victoria's real time prescription monitoring system (SafeScript) on a cohort of people who inject drugs. Medical Journal of Australia. doi:10.5694/mja2.50659

Fischer, B., Lee, A., O'Keefe-Markman, C., & Hall, W. (2020). Initial indicators of the public health impacts of non-medical cannabis legalization in Canada. EClinicalMedicine, 20. doi:10.1016/j.eclinm.2020.100294

Forbes, E., et al., Non-pharmacological approaches to procedural anxiety reduction for patients undergoing radiotherapy for cancer: Systematic review protocol. BMJ Open, 2020. 10(10).

Frude, E., McKay, F. H., & Dunn, M. (2020). A focused netnographic study exploring experiences associated with counterfeit and contaminated anabolic-androgenic steroids. Harm Reduction Journal, 17(1). doi:10.1186/s12954-020-00387-y

Giles, A., et al., Exercise as Treatment for Youth With Major Depression: The Healthy Body Healthy Mind Feasibility Study. Journal of psychiatric practice, 2020. 26(6): p. 444-460.

González, R. A., Vélez-Pastrana, M. C., Blankers, M., Bäcker, A., Konstenius, M., Holtmann, M., Levin, F. R., Noack, M., Kaye, S., Demetrovics, Z., van den Glind,, G., van den Brink, W., & Schellekens, A. (2020). Onset and severity of early disruptive behavioral disorders in treatment-seeking substance use disorder patients with and without attention-deficit/hyperactivity disorder. European Addiction Research, 1-12. doi:10.1159/000508653

Graham, M., Lucas, C. J., Schneider, J., Martin, J. H., & Hall, W. (2020). Translational hurdles with cannabis medicines. Pharmacoepidemiology and Drug Safety. doi:10.1002/pds.4999

Greenwood, C.J., et al., A comparison of penalised regression methods for informing the selection of predictive markers. PLoS ONE, 2020. 15(11 November).